Advances in the radiotherapy of brain metastases

D. Antoni (Strasbourg, France)

Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
Session: Which treatment other than chemotherapy for stage IV NSCLC?
Session type: Symposium
Number: 1464
Disease area: Thoracic oncology

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Antoni (Strasbourg, France). Advances in the radiotherapy of brain metastases. Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multimodal management of brain metastases in lung cancer
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018


Whole brain re-irradiation in lung cancer patients with multiple brain metastases
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011

Whole brain radiotherapy for brain – only metastases of small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 755s
Year: 2006

Is there a role for radiotherapy in mediastinal tumours?
Source: Annual Congress 2013 –Mediastinal tumours excluding thymoma
Year: 2013


Palliative radiotherapy for brain- only metastases of non small cell lung cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008

Treatment modalities in lung cancer patients with brain metastasis
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012

The estimations of two regimenes of radiation of brain metastases in patients with primary lung cancer
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007


Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC
Source: Eur Respir J 2012; 39: 1039-1042
Year: 2012


Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Brain metastases in lung cancer patients
Source: International Congress 2019 – ME4 Brain metastases in lung cancer patients.
Year: 2019


Temozolomide in the treatment of brain metastases in lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 65s
Year: 2003

Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 664s
Year: 2007

Cryotherapy as an adjuvant to radiotherapy in lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 76s
Year: 2005

Multimodality lung cancer therapy – nonsurgical complications
Source: Annual Congress 2008 - High-risk patients for major lung cancer surgery
Year: 2008


Toxicity in isolated lung perfusion with melphalan for resectable lung metastases
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006


Current challenges in the management of nonsmall cell lung cancer brain metastases
Source: Eur Respir J, 55 (1) 1901686; 10.1183/13993003.01686-2019
Year: 2020